Stocks and InvestingStocks and Investing
Tue, October 3, 2023
Mon, October 2, 2023
Sun, October 1, 2023
Fri, September 29, 2023

Luke Sergott Maintained (TXG) at Buy with Decreased Target to $47 on, Sep 29th, 2023


Published on 2024-10-28 06:38:35 - WOPRAI, Luke Sergott
  Print publication without navigation


Luke Sergott of Barclays, Maintained "10x Genomics, Inc." (TXG) at Buy with Decreased Target from $66 to $47 on, Sep 29th, 2023.

Luke has made no other calls on TXG in the last 4 months.



There are 4 other peers that have a rating on TXG. Out of the 4 peers that are also analyzing TXG, 0 agree with Luke's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Luke


  • Kyle Mikson of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $70 on, Tuesday, September 19th, 2023
  • Tejas Savant of "Morgan Stanley" Reiterated at Buy and Held Target at $65 on, Monday, August 7th, 2023
  • Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Increased Target to $75 on, Friday, August 4th, 2023
  • Matthew Sykes of "Goldman Sachs" Maintained at Strong Sell with Increased Target to $30 on, Thursday, July 13th, 2023